SEC 13F Intelligence

Ghost Tree Capital, LLC / ACRS

Ghost Tree Capital, LLC’s Aclaris Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Aclaris Therapeutics Inc (ACRS)? Not currently — the last reported position was 425.0K shares worth $3M in Q1 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$3M
Q1 2023
Shares
425.0K
% of Portfolio
+1.02%
Quarters Held
7
position exited

Position History ACRS

Reported value by quarter
Q4 ’20: $4MQ4 ’20Q1 ’21: $15MQ1 ’21Q2 ’21: $4MQ2 ’21Q3 ’21: $5MQ3 ’21Q4 ’21: $5MQ4 ’21Q1 ’22: $2MQ1 ’22Q1 ’23: $3MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2023425.0K$3M+1.02%
Q1 2022125.0K$2M+0.47%
Q4 2021325.0K$5M+1.69%
Q3 2021275.0K$5M+1.45%
Q2 2021250.0K$4M+1.21%
Q1 2021600.0K$15M+3.55%
Q4 2020650.0K$4M+0.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of ACRS.